Valerenic acid
Clinical trialMechanism of Action
Research Notes
Primary anxiolytic compound. GABA-A β3 selectivity demonstrated by Khom et al. Sedative effects enhanced by valepotriates. Clinical data largely extrapolated from V. officinalis.
Valerenic acid is the primary anxiolytic and sedative compound. Multiple RCTs demonstrate improved sleep quality with 300-600mg valerian extract. Meta-analysis supports modest but significant sleep benefits.
Found In 2 Herbs
3D Molecular Structure
Valerenic acid
Representative pattern: C₁₀H₁₆O
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
